Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.

NCT06928883 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Coronary Arterial Disease (CAD)
Vulnerable Coronary Plaques
Multivessel Coronary Artery Disease
Coronary Vessel
Acute Coronary Syndromes (ACS)

Interventions

DEVICE: Sirolimus drug eluting ballooon therapy
DRUG: Optimal guidelines-directed medical therapies (GDMT)

Sponsor

Cardiocentro Ticino